Luca Guarnera

Rome, 00133, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

FLT3-ITD Measurable Residual Disease in Acute Myeloid Leukemia: Implications for FLT3 Inhibitor-Based Therapies.

FLT3-ITD Measurable Residual Disease in Acute Myeloid Leukemia: Implications for FLT3 Inhibitor-Based Therapies.

Journal: Cancers

Published: July 14, 2026

De novo JAK2-mutated acute myeloid leukaemia: Clinical outcomes and molecular features.

De novo JAK2-mutated acute myeloid leukaemia: Clinical outcomes and molecular features.

Journal: British journal of haematology

Published: April 23, 2026

Molecular and clinical analyses of c-CBL mutations affecting tyrosine 371 in myelodysplastic and proliferative disorders.

Molecular and clinical analyses of c-CBL mutations affecting tyrosine 371 in myelodysplastic and proliferative disorders.

Journal: Leukemia

Published: April 02, 2026

Multilineage lymphoid clonal hematopoiesis: a cross-sectional, correlative analysis of plasma cell dyscrasias and large granular lymphocytic leukemia.

Multilineage lymphoid clonal hematopoiesis: a cross-sectional, correlative analysis of plasma cell dyscrasias and large granular lymphocytic leukemia.

Journal: Leukemia

Published: March 24, 2026

Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drives.

Lessons of nature from trisomy-8 myeloid neoplasia: the riddle of oncogenic clonal drives.

Journal: Haematologica

Published: March 06, 2026

Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Normal life expectancy after all-trans retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Journal: Leukemia

Published: February 05, 2026

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

An Immune Dysfunction Signature Score Predicts Survival in MDS Patients: Insights From a Longitudinal, Multicenter Study.

Journal: Cancer science

Published: December 26, 2025

Multi-modal AI in precision medicine: integrating genomics, imaging, and EHR data for clinical insights.

Multi-modal AI in precision medicine: integrating genomics, imaging, and EHR data for clinical insights.

Journal: Frontiers in artificial intelligence

Published: November 11, 2025

Validation of ICC hierarchical classification in secondary AML.

Validation of ICC hierarchical classification in secondary AML.

Journal: Blood advances

Published: August 26, 2025

Validation of ICC hierarchical classification in secondary AML.

Validation of ICC hierarchical classification in secondary AML.

Journal: Blood advances

Published: August 26, 2025

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: August 18, 2025

IDH1 mutation in acute lymphoblastic leukemia-A rare but significant finding.

IDH1 mutation in acute lymphoblastic leukemia-A rare but significant finding.

Journal: Current research in translational medicine

Published: July 04, 2025

Showing 1-12 of 66

Last Updated: 09/26/2026